Cancer News and Research

Latest Cancer News and Research

Biokine, BioLineRx sign license agreement to develop and commercialize BL-8040 for AML

BioLineRx Ltd., a biopharmaceutical drug development company, announced today that it has signed an exclusive, worldwide license agreement with Biokine Therapeutics Ltd., a Clal Biotechnology Industries portfolio company, for the development and commercialization of BL-8040 (formerly BKT-140), a Phase II ready drug candidate for the treatment of acute myeloid leukemia (AML), as well as other types of hematological cancer.

4 Sep 2012

EC grants marketing authorization for Pfizer’s INLYTA to treat renal cell carcinoma

Pfizer Inc. announced today that the European Commission (EC) has granted marketing authorization for INLYTA (axitinib) for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of kidney cancer, after failure of prior treatment with sunitinib or a cytokine.

4 Sep 2012

Ultrastable RNA nanoparticles may help treat cancer and viral infections

A new study by University of Kentucky researchers shows promise for developing ultrastable RNA nanoparticles that may help treat cancer and viral infections by regulating cell function and binding to cancers without harming surrounding tissue.

4 Sep 2012

Scientists discover new anti-cancer and anti-metastatic molecule

A new molecule with anti-cancer and anti-metastatic properties has been discovered by teams from CNRS, CEA, the Institut Curie and Inserm, in collaboration with Australian and British researchers.

4 Sep 2012

GE Healthcare introduces KUBio factory

GE Healthcare, the healthcare business of GE, today introduced KUBio, an innovative off-the-shelf, modular factory designed to save manufacturers of biopharmaceuticals both time and money.

4 Sep 2012

Converting blood cells to a stem cell state: an interview with Elias Zambidis, M.D., Ph.D.

The primitive stem cell state we created is called an “induced pluripotent stem cell” (iPSC). iPSC are a new, unique, and artificially-created type of stem cell that were first described in 2006 by a Japanese scientist named Shinya Yamanaka.

4 Sep 2012

FDA approves Novartis’ Exelon Patch to treat mild to moderate AD

The US Food and Drug Administration has approved a higher dose of Exelon Patch (rivastigmine transdermal system) for the treatment of people with mild to moderate Alzheimer's disease.

4 Sep 2012

PRISM technique as accurate as ELISAs in identifying proteins within biological samples

Combining two well-established analytic techniques and adding a twist identifies proteins from blood with as much accuracy and sensitivity as the antibody-based tests used clinically, researchers report this week in Proceedings of the National Academy of Sciences Early Edition online.

4 Sep 2012

Parkinson disease may share common pathogenic mechanisms with some cancers

A study that used a Utah genealogic database and a statewide cancer registry to examine the relationship between Parkinson disease (PD) and cancer suggests an increased risk of prostate cancer and melanoma in patients with PD and their relatives, according to a report published Online First by Archives of Neurology, a JAMA Network publication.

4 Sep 2012

Exercise paves way to healthy old age

Middle-aged people who have a high level of physical fitness have a significantly lower and later incidence of chronic conditions in old age than those who are less fit, report researchers.

3 Sep 2012

Usefulness of liver biopsy for CALI preoperative assessment questioned

Liver biopsy is not a reliable tool for preoperative assessment of chemotherapy-associated liver injuries except for steatosis, suggest study findings published in the Archives of Surgery.

3 Sep 2012

VIDA releases Apollo 1.2 SaaS for endobronchial emphysema treatment

VIDA Diagnostics, a leading developer of quantitative imaging analysis software for the diagnosis and treatment planning of major pulmonary disease, announced today the release and commercial availability of Apollo 1.2, here at the European Respiratory Society (ERS) meeting in Vienna, Austria.

3 Sep 2012

Obesity and breast cancer recurrence: an interview with Dr. Joseph Sparano

Breast cancer recurrence is a major problem after treatment of localized breast cancer. The risk of recurrence depends on several factors including the stage of presentation and the biology of the disease.

3 Sep 2012

Boehringer Ingelheim announces data from olodaterol plus tiotropium Phase II COPD study

Boehringer Ingelheim presented today for the first time data from a Phase II dose ranging study investigationg the combination of olodaterol, an investigational long-acting beta2-agonist (LABA), and tiotropium, a long-acting muscarinic antagonist (LAMA), in COPD patients, compared to the investigational agent olodaterol alone.

3 Sep 2012

Researchers measure highest DDT levels in breast milk from South African nursing mothers

The highest levels ever of DDT in breast milk have been measured in mothers living in malaria-stricken villages in South Africa. The values lie well over the limits set by the World Health Organization. DDT has been used for many years in South Africa, sprayed indoors to fight malaria.

3 Sep 2012

New drug combines photothermia and chemotherapy to help fight cancer

Spanish researchers have developed on a nanometric scale a new drug that combines photothermia and chemotherapy to help fight cancer.

3 Sep 2012

First data from Boehringer Ingelheim’s Respimat Phase III asthma program

Boehringer Ingelheim presented today the first data from the Phase III UniTinA-asthma program. In two studies, presented at the 2012 European Respiratory Society (ERS) Congress in Vienna, Austria, tiotropium delivered once daily via the Respimat inhaler significantly improved lung function and reduced asthma exacerbations in patients who remained symptomatic on current treatment with at least high dose inhaled corticosteroids (ICS) and long-acting beta agonists (LABA).

3 Sep 2012

Triple-threat approach can reduce invasive bloodstream infections in pediatric cancer patients

Hospitals can dramatically reduce the number of life-threatening central line infections in pediatric cancer patients by following a set of basic precautions, by encouraging families to speak up when they observe noncompliance with the protocol and by honest analysis of the root cause behind every single infection, according to a new Johns Hopkins Children's Center study.

3 Sep 2012

Policymakers need to continue funding for adolescent smoking prevention programs: WSU

While many might see the case for programs to prevent adolescent cigarette smoking as already made, a pair of Wayne State University researchers believes that due to increasingly challenging economic times, policymakers need to be reminded to continue allocating funding for such programs.

3 Sep 2012

AIDS experts develop first accurate computer simulation to explain drug effects

Pooling data from thousands of tests of the antiviral activity of more than 20 commonly used anti-HIV drugs, AIDS experts at Johns Hopkins and Harvard universities have developed what they say is the first accurate computer simulation to explain drug effects. Already, the model clarifies how and why some treatment regimens fail in some patients who lack evidence of drug resistance.

3 Sep 2012

Cancer News and Research

Latest Cancer News and Research

Biokine, BioLineRx sign license agreement to develop and commercialize BL-8040 for AML

EC grants marketing authorization for Pfizer’s INLYTA to treat renal cell carcinoma

Ultrastable RNA nanoparticles may help treat cancer and viral infections

Scientists discover new anti-cancer and anti-metastatic molecule

GE Healthcare introduces KUBio factory

Converting blood cells to a stem cell state: an interview with Elias Zambidis, M.D., Ph.D.

FDA approves Novartis’ Exelon Patch to treat mild to moderate AD

PRISM technique as accurate as ELISAs in identifying proteins within biological samples

Parkinson disease may share common pathogenic mechanisms with some cancers

Exercise paves way to healthy old age

Usefulness of liver biopsy for CALI preoperative assessment questioned

VIDA releases Apollo 1.2 SaaS for endobronchial emphysema treatment

Obesity and breast cancer recurrence: an interview with Dr. Joseph Sparano

Boehringer Ingelheim announces data from olodaterol plus tiotropium Phase II COPD study

Researchers measure highest DDT levels in breast milk from South African nursing mothers

New drug combines photothermia and chemotherapy to help fight cancer

First data from Boehringer Ingelheim’s Respimat Phase III asthma program

Triple-threat approach can reduce invasive bloodstream infections in pediatric cancer patients

Policymakers need to continue funding for adolescent smoking prevention programs: WSU

AIDS experts develop first accurate computer simulation to explain drug effects

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in